Related Experiment Video

Updated: Oct 25, 2026

Mouse Models Of Helicobacter Infection And Gastric Pathologies
07:43

Mouse Models Of Helicobacter Infection And Gastric Pathologies

Published on: October 18, 2018

[Fas/Fas ligand mRNA are expressed in Helicobacter pylori infected mucosa]

F Meyer1, S P James

  • 1Otto-von-Guericke Universität, Zentrum für Chirurgie, Magdeburg.

Langenbecks Archiv Fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress
|February 5, 1999
PubMed

Insights

Helicobacter pylori (Hp) infection may impact immune responses. Researchers found Fas and FasLigand are present in the stomach lining, suggesting a role in regulating immune responses and causing tissue damage during Hp gastritis.

Area of Science:

  • Gastroenterology
  • Immunology
  • Pathology

Background:

  • Helicobacter pylori (Hp) is a bacterium known to cause gastritis and peptic ulcers.
  • Hp infection has immunomodulatory and inflammatory effects on the gastric mucosa.
  • The role of specific immune pathways, such as the Fas/FasL system, in Hp gastritis is not fully understood.

Purpose of the Study:

  • To investigate the expression of Fas and FasLigand in the gastric mucosa of patients with and without Hp infection.
  • To compare the expression of Fas and FasLigand in gastric mucosa with peripheral blood mononuclear cells (PBMC).
  • To explore the potential role of Fas-FasLigand interaction in the immune regulation and epithelial injury associated with Hp gastritis.

Main Methods:

  • Analysis of Fas and FasLigand expression in gastric mucosal biopsies.
  • Comparison of expression levels between Hp-infected and non-infected individuals.
  • Assessment of Fas and FasLigand expression in PBMC for comparative analysis.

Main Results:

  • Both Fas and FasLigand were expressed in the gastric mucosa.
  • Expression levels of Fas and FasLigand in the gastric mucosa were similar regardless of Hp infection status.
  • No significant difference was observed in Fas/FasLigand expression between gastric mucosa and PBMC.

Conclusions:

  • Fas-FasLigand interaction may be involved in the immune regulation of Helicobacter pylori gastritis.
  • The Fas-FasLigand pathway could contribute to the induction or mediation of epithelial injury in Hp gastritis.
  • Further research is warranted to elucidate the precise mechanisms of Fas-FasLigand in Hp-associated gastric pathology.

More Related Videos

Expression, Purification, and Antimicrobial Activity of S100A1211:10

Expression, Purification, and Antimicrobial Activity of S100A12

Published on: May 13, 2017

High Resolution Electron Microscopy of the Helicobacter pylori Cag Type IV Secretion System Pili Produced in Varying Conditions of Iron Availability09:05

High Resolution Electron Microscopy of the Helicobacter pylori Cag Type IV Secretion System Pili Produced in Varying Conditions of Iron Availability

Published on: November 21, 2014

Related Concept Videos

Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...